Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1997-11-12
1999-12-14
Fitzgerald, David L.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 697, 435 681, 530430, 530412, C07K 1107, C07K 136
Patent
active
060016043
ABSTRACT:
An improved and efficient process for the production of recombinant human insulin by folding of a proinsulin hybrid polypeptide is provided.
REFERENCES:
patent: H245 (1987-04-01), Bahl
patent: 3420810 (1969-01-01), Katsoyannis et al.
patent: 3847893 (1974-11-01), Brandenburg et al.
patent: 4014861 (1977-03-01), Geiger et al.
patent: 4338397 (1982-07-01), Gilbert et al.
patent: 4421685 (1983-12-01), Chance et al.
patent: 4430266 (1984-02-01), Frank
patent: 4431740 (1984-02-01), Bell et al.
patent: 4440859 (1984-04-01), Rutter et al.
patent: 4569791 (1986-02-01), Frank et al.
patent: 4616078 (1986-10-01), DiMarchi et al.
patent: 4704362 (1987-11-01), Itakura et al.
patent: 4792602 (1988-12-01), Narang et al.
patent: 4916212 (1990-04-01), Markussen et al.
patent: 4999422 (1991-03-01), Galliher et al.
patent: 5015575 (1991-05-01), Brake et al.
patent: 5149777 (1992-09-01), Hansen et al.
patent: 5342921 (1994-08-01), Cousens et al.
Scopes, R. (1982) Protein Purification: Principles of Practice, New York: Springer-Verlag, pp. 25-30, 81-84, 139-141, 182-183.
Gorecki Marian
Hartman Jacob R.
Mendelovitz Simona
Bio-Technology General Corp.
Fitzgerald David L.
White John P.
LandOfFree
Refolding of proinsulins without addition of reducing agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Refolding of proinsulins without addition of reducing agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Refolding of proinsulins without addition of reducing agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-862173